# US 2019/0378598 A1 · Centralized pharmacy for validating prescription drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0378598 A1
- Document ID: US20190378598A1
- Status: Published application
- Kind: A1
- Application number: 16/001,737
- Filed: 2018-06-06
- Published: 2019-12-12
- Earliest claimed: 2018-06-06
- Assignees: Nimble Rx, Inc.
- Applicants: Nimble Rx, Inc.
- Inventors: Shaun Johnson; Zoe Cohen; Talha Waqar
- Web page: https://patentgrep.com/patent/US20190378598A1

## CPC

- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G06Q 40/08: Insurance
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR

## Abstract

A centralized pharmacy validates a drug prescribed by a physician for a patient to ensure that the prescribed drug is a safe and cost effective treatment for the patient. The centralized pharmacy accesses the medical history of the patient, drug information of the prescribed drug, the insurance health plan purchased by the patient, as well as drug abuse information. The centralized pharmacy performs the validation process using the accessed information. If the centralized pharmacy successfully validates the prescribed drug, the centralized pharmacy physically dispatches the prescribed drug to the patient. Alternatively, if the centralized pharmacy determines that the prescribed drug fails the validation process, the centralized pharmacy can identify an alternate drug and validates the alternate drug. Therefore, the centralized pharmacy can automatically replace the prescribed drug with a more appropriate, alternate drug and can dispatch the alternate drug to the patient.

## Claims

### Claim 1

A method for providing a prescription drug to a patient, the method comprising:
receiving a prescription identifying a prescribed drug for a patient;
accessing patient information from a patient profile of the patient, the patient profile including a medical history of the patient;
accessing drug information for the prescribed drug from a drug data store describing at least drug interactions related to the prescribed drug;
performing a safety validation of the prescribed drug for the patient based on the patient information accessed from the patient profile of the patient and drug information accessed from the drug data store;
accessing an insurance plan of the patient from an insurance data store, the insurance plan including at least an indication as to whether the prescribed drug is covered by the insurance plan;
performing a cost validation of the prescribed drug for the patient based on the insurance plan accessed from the insurance data store; and
based on the safety validation and the cost validation, providing the prescribed drug to the patient.

### Claim 2 (depends on 1)

The method of claim 1, wherein providing the prescribed drug to the patient further comprises:
providing, for display on a user kiosk to the patient, the prescription identifying the prescribed drug for the patient;
receiving a confirmation from the user kiosk, the confirmation including an address of delivery; and
providing the prescribed drug to the address of delivery included in the confirmation.

### Claim 3 (depends on 1)

The method of claim 1, wherein performing the safety validation comprises:
comparing the patient information of the patient to each of a plurality of subcategories of the drug information for the prescribed drug, the plurality of subcategories comprising drug treatment information of the prescribed drug, risk information of the prescribed drug, and relevant additional drug information.

### Claim 4 (depends on 1)

The method of claim 1, wherein in response to the prescribed drug failing the safety validation, providing a notification for display on a client device, the notification identifying that the prescribed drug failed the safety validation.

### Claim 5 (depends on 1)

The method of claim 1, wherein performing the cost validation comprises:
determining whether the accessed insurance plan of the patient covers the prescribed drug; and
determining whether the prescribed drug satisfies restrictions placed by an insurer, the restrictions comprising a quantity limit for the prescribed drug.

### Claim 6 (depends on 1)

The method of claim 1, further comprising:
prior to providing the prescribed drug to the patient, accessing drug abuse information from a drug abuse data store, the drug abuse information identifying that the prescribed drug is prone to abuse; and
performing a third validation of the prescribed drug for the patient based on drug abuse information accessed from the drug abuse data store,
wherein providing the prescribed drug to the patient is further based on the third validation.

### Claim 7 (depends on 7)

The method of claim 7, wherein the third validation is further performed based on the patient information accessed from the patient profile of the patient.

### Claim 8

A method for providing a prescription drug to a patient, the method comprising:
receiving a prescription identifying a prescribed drug for a patient;
accessing patient information from a patient profile of the patient, the patient profile including a medical history of the patient;
accessing drug information for the prescribed drug from a drug data store describing at least drug interactions related to the prescribed drug;
performing a safety validation of the prescribed drug for the patient based on the patient information accessed from the patient profile of the patient and drug information accessed from the drug data store;
accessing an insurance plan of the patient from an insurance data store, the insurance plan including at least an indication as to whether the prescribed drug is covered by the insurance plan;
performing a cost validation of the prescribed drug for the patient based on the insurance plan accessed from the insurance data store; and
based on the safety validation and cost second validation, providing an instruction indicating that the prescribed drug is to be dispatched to the patient.

### Claim 9 (depends on 8)

The method of claim 8, wherein providing the instruction indicating that the prescribed drug is to be dispatched to the patient further comprises:
providing, for display on a user kiosk to the patient, the prescription identifying the prescribed drug for the patient; and
receiving a confirmation from the user kiosk, the confirmation including an address of delivery,
wherein the provided instruction includes the address of delivery included in the confirmation.

### Claim 10 (depends on 8)

The method of claim 8, wherein performing the safety validation comprises:
comparing the patient information of the patient to each of a plurality of subcategories of the drug information for the prescribed drug, the plurality of subcategories comprising drug treatment information of the prescribed drug, risk information of the prescribed drug, and relevant additional drug information.

### Claim 11 (depends on 8)

The method of claim 8, wherein in response to the prescribed drug failing the safety validation, providing a notification for display on a client device, the notification identifying that the prescribed drug failed the safety validation.

### Claim 12 (depends on 8)

The method of claim 8, wherein performing the cost validation comprises:
determining whether the accessed insurance plan of the patient covers the prescribed drug; and
determining whether the prescribed drug satisfies restrictions placed by an insurer, the restrictions comprising a quantity limit for the prescribed drug.

### Claim 13 (depends on 8)

The method of claim 8, further comprising:
prior to providing the prescribed drug to the patient, accessing drug abuse information from a drug abuse data store, the drug abuse information identifying that the prescribed drug is prone to abuse; and
performing a third validation of the prescribed drug for the patient based on drug abuse information accessed from the drug abuse data store,
wherein providing the prescribed drug to the patient is further based on the third validation.

### Claim 14 (depends on 13)

The method of claim 13, wherein the third validation is further performed based on the patient information accessed from the patient profile of the patient.

### Claim 15

A method for providing a prescription drug to a patient, the method comprising:
receiving a prescription identifying a prescribed drug for a patient;
accessing patient information from a patient profile of the patient, the patient profile including a medical history of the patient;
accessing drug information for the prescribed drug from a drug data store describing at least drug interactions related to the prescribed drug;
performing a safety validation of the prescribed drug for the patient based on the patient information accessed from the patient profile of the patient and drug information accessed from the drug data store;
responsive to a failure of the validation of the prescribed drug, modifying the prescription by replacing the prescribed drug with an alternate drug representing an alternative to the prescribed drug;
accessing an insurance plan of the patient from an insurance data store, the insurance plan including at least an indication as to whether the alternate drug is covered by the insurance plan;
performing a cost validation of the alternate drug for the patient based on the insurance plan accessed from the insurance data store; and
based on the safety validation and the cost validation, providing an instruction indicating that the prescribed drug is to be dispatched to the patient.

### Claim 16 (depends on 15)

The method of claim 15, wherein providing the instruction indicating that the prescribed drug is to be dispatched to the patient further comprises:
providing, for display on a user kiosk to the patient, the prescription identifying the prescribed drug for the patient; and
receiving a confirmation from the user kiosk, the confirmation including an address of delivery,
wherein the provided instruction includes the address of delivery included in the confirmation.

### Claim 17 (depends on 15)

The method of claim 15, wherein performing the safety validation of the prescribed drug for the patient comprises:
comparing the patient information of the patient to each of a plurality of subcategories of the drug information for the prescribed drug, the plurality of subcategories comprising drug treatment information of the prescribed drug, risk information of the prescribed drug, and relevant additional drug information.

### Claim 18 (depends on 15)

The method of claim 15, wherein modifying the prescription by replacing the prescribed drug with an alternate drug comprises:
identifying the alternate drug included in a subcategory of the drug information for the prescribed drug, the alternate drug having a different mode of action in comparison to the prescribed drug; and
performing a safety validation of the alternate drug to ensure that the alternate drug can be safely taken by the patient,
wherein the prescription is modified in response to the alternate drug passing the safety validation.

### Claim 19 (depends on 15)

The method of claim 15, wherein performing the cost validation of the alternate drug comprises:
determining whether the accessed insurance plan of the patient covers the alternate drug; and
determining whether the alternate drug satisfies restrictions placed by an insurer, the restrictions comprising a quantity limit for the alternate drug.

### Claim 20 (depends on 15)

The method of claim 15, further comprising:
prior to providing the alternate drug to the patient, accessing drug abuse information from a drug abuse data store, the drug abuse information identifying that the alternate drug that is prone to abuse; and
performing a third validation of the alternate drug for the patient based on drug abuse information accessed from the drug abuse data store,
wherein providing the alternate drug to the patient is further based on the third validation.